Cameron Turtle owns 0.61% of Spyre Therapeutics
537,540 shares as of the October 1, 2026 filing, worth $42.9M at the latest close.
SYRE · $7B market capGet an email when Cameron Turtle’s stake moves.
Free.
The stake
0.61%
worth $42.9M at the latest close
Stake rank
#789
by dollar value of the stake
Last sale
18 days ago
Oct 1, 2026
Last buy
None
no purchases since 2025
Cameron Turtle owns 0.61% of Spyre Therapeutics, Inc.: 537,540 of 88,173,762 shares, worth about $42.9M at the 2026-10-16 close. The stake has moved from 0.88% in 2023 to 0.61% on 2026-10-01, across 12 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $1.4M on 2026-10-01.
How the stake is held
as of the Oct 1, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 1, 2026 · Form 4 ↗
HELD DIRECTLY
537,540
100.0%
THE STAKE
537,540
0.61%